Verified Nov 2026
Other
·

Richmond, Virginia
·
Since 2014
Indivior is a specialty pharmaceutical company headquartered in Richmond, Virginia, founded in 2014, with 500–1,000 employees and estimated revenue of $1–5 billion. It develops and manufactures buprenorphine-based medications and other therapeutics for opioid use disorder, overdose reversal, and mental health conditions, operating across more than 30 countries. The company completed a merger with Supernus Pharmaceuticals in November 2026.
Indivior at a glance
Revenue
$1-5B
Est. band
Employees
500-1,000
Founded
2014
Headquarters
Richmond, Virginia
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Indivior is a specialty pharmaceutical company headquartered in Richmond, Virginia, founded in 2014, with 500–1,000 employees and estimated revenue of $1–5 billion. It develops and manufactures buprenorphine-based medications and other therapeutics for opioid use disorder, overdose reversal, and mental health conditions, operating across more than 30 countries. The company completed a merger with Supernus Pharmaceuticals in November 2026.
At a glance
Attribute | Detail |
|---|---|
Founded | 2014 |
Headquarters | Richmond, Virginia |
Employees | 500-1,000 |
Revenue | $1-5B (estimated) |
What Indivior makes
The company produces long-acting injectable formulations and oral medications including SUBLOCADE, SUBOXONE, and Opvee for addiction treatment and overdose reversal.
Latest developments
2026-11-02 — Supernus and Indivior Complete Merger Creating a Diversified CNS Biopharmaceutical Leader - Supernus Pharmaceuticals (supernus.com)
2026-10-29 — Indivior Reports Third Quarter 2026 Financial Results | Thu, 10/29/2026 - 07:00 (indivior.com)
2026-08-03 — Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale | Mon, 08/03/2026 - 06:30 (indivior.com)
2026-02-26 — Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results | Thu, 02/26/2026 - 07:00 (indivior.com)
2026-02-24 — Indivior selects Havas U.S. integrated AOR (mmm-online.com)
2026-01-08 — Indivior Provides Full-Year 2026 Financial Guidance and Business Update | Thu, 01/08/2026 - 07:00 (indivior.com)
Facilities
Indivior is headquartered in Richmond, Virginia. Public sources also reference these locations:
Fort Collins, Colorado — indivior.com
Raleigh, North Carolina — indivior.com
Company details
Indivior operates manufacturing and research facilities in Fort Collins, Colorado and Raleigh, North Carolina, serving healthcare providers and healthcare systems primarily in the United States and Europe. Indivior was founded in 2014, has an estimated 500-1,000 employees, and is headquartered in Richmond, Virginia.
Frequently asked questions
What does Indivior do?
Indivior is a specialty pharmaceutical company headquartered in Richmond, Virginia, founded in 2014, with 500–1,000 employees and estimated revenue of $1–5 billion. It develops and manufactures buprenorphine-based medications and other therapeutics for opioid use disorder, overdose reversal, and mental health conditions, operating across more than 30 countries. The company completed a merger with Supernus Pharmaceuticals in November 2026.
Where is Indivior headquartered?
Indivior is headquartered in Richmond, Virginia (10710 Midlothian Turnpike, Richmond, Virginia, 23235).
When was Indivior founded?
Indivior was founded in 2014.
How big is Indivior?
Indivior has an estimated 500-1,000 employees, with revenue in the $1-5B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
